| 1998 |
PDZK1 was identified as a novel 519-amino acid protein containing four PDZ protein interaction domains, discovered by yeast two-hybrid screening of a human kidney cDNA library using MAP17 as bait. PDZK1 colocalized with MAP17 in the brush border of proximal tubular epithelial cells of the kidney. |
Yeast two-hybrid screening, in situ hybridization, co-localization |
Laboratory investigation |
Medium |
9461128
|
| 2003 |
PDZK1 knockout mice lack overt phenotype but show modulation of selective ion channel expression in the kidney and increased serum cholesterol levels; PDZK1 loss did not significantly redistribute MAP17, cMOAT, or the type IIa Na/Pi cotransporter, suggesting functional compensation by other PDZ proteins. |
Homologous recombination knockout mouse, Western blot, serum cholesterol measurement |
Molecular and cellular biology |
High |
12556478
|
| 2003 |
MAP17 interacts specifically with the fourth PDZ domain of PDZK1 (but not with other PDZ proteins in proximal tubular brush borders), and MAP17 acts as an apical anchoring site for PDZK1, as apical localization of PDZK1 is dependent on MAP17 but not vice versa. |
Yeast two-hybrid, in vitro binding assays, immunofluorescence, transfection in opossum kidney cells |
American journal of physiology. Renal physiology |
Medium |
12837682
|
| 2003 |
PDZK1 anchors the dual-specific A-kinase anchoring protein D-AKAP2 to the subapical membrane of renal proximal tubular cells via PDZ domain 4 of PDZK1, thereby compartmentalizing PKA activity near NaPi-IIa to enable PTH-mediated regulation. |
Yeast two-hybrid, pull-down assays, co-immunoprecipitation from transfected OK cells, immunohistochemistry, real-time PCR |
Kidney international |
Medium |
14531807
|
| 2005 |
PDZK1 is required for normal brush-border expression and function of the Cl-anion exchanger CFEX (SLC26A6/PAT1) in renal proximal tubule; PDZK1 directly binds NHE3 and CFEX via their C-terminal PDZ-interaction sites. Loss of PDZK1 markedly reduced CFEX protein expression and Cl-oxalate exchange activity, while NHE3 brush-border expression was unaffected. |
GST pull-down with native brush border membrane proteins, Western blot, immunocytochemistry, brush border membrane vesicle transport assay, microperfused proximal tubule volume absorption, PDZK1-null mice |
Proceedings of the National Academy of Sciences of the United States of America |
High |
16141316
|
| 2005 |
PDZK1 controls hepatic SR-BI protein levels in a posttranscriptional manner; phosphorylation of PDZK1 at Ser-509 by PKA (stimulated by glucagon) is required for PDZK1 to upregulate SR-BI protein expression. Mutation of Ser-509 to Ala abolishes the ability of PDZK1 to upregulate SR-BI. |
Metabolic labeling, phosphoamino acid analysis, site-directed mutagenesis, in vitro kinase assay with PKA, cell culture overexpression, phospho-specific antibody, glucagon administration to rats |
Proceedings of the National Academy of Sciences of the United States of America |
High |
16174736
|
| 2005 |
PDZK1 interacts with organic anion transporter Oatp1a1 via its C-terminal PDZ-interaction site, predominantly at the first and third PDZ domains of PDZK1; PDZK1 is required for basolateral plasma membrane localization of Oatp1a1 in hepatocytes—in PDZK1 knockout liver, Oatp1a1 is retained in intracellular structures, impairing hepatic organic anion transport. |
C-terminal peptide affinity isolation, protein mass fingerprinting, co-immunoprecipitation from cotransfected 293T cells and native rat liver membranes, immunofluorescence, radiolabeled substrate plasma disappearance in PDZK1-KO mice |
The Journal of biological chemistry |
High |
15994332
|
| 2005 |
PDZK1 (CAP70) interacts with the intestinal anion exchanger DRA via the DRA C-terminal PDZ interaction motif, binding at the 2nd and 3rd PDZ domains of PDZK1/CAP70, distinct from CFTR which binds PDZ1, PDZ3, and PDZ4. |
Overlay assay with recombinant DRA C-terminus, anti-CAP70 antibody identification, in vitro binding assays, co-immunoprecipitation in transfected HEK cells |
Biochemistry |
Medium |
15766278
|
| 2005 |
PDZK1 interacts with SSTR5 (somatostatin receptor subtype 5) at the plasma membrane via the PDZ ligand motif at the C-terminus of SSTR5; PDZK1 is required for post-endocytic recycling of SSTR5 back to the plasma membrane after agonist-induced internalization. |
Yeast two-hybrid, co-localization studies, receptor recycling assay in transfected cells |
The Journal of biological chemistry |
Medium |
16012170
|
| 2006 |
PDZK1 interacts with human PEPT2 (SLC15A2) via PDZ motif of the PEPT2 C-terminus, binding at the 2nd and 3rd PDZ domains of PDZK1; PDZK1 co-expression increases V(max) of glycylsarcosine transport by PEPT2 by increasing PEPT2 surface expression. |
Yeast two-hybrid, in vitro binding assay, co-immunoprecipitation (human kidney membrane fraction), surface plasmon resonance for binding affinities, functional transport assay in HEK293 cells |
Kidney international |
High |
16738539
|
| 2006 |
MAP17 interacts with all four NHERF family proteins (including PDZK1/NHERF3) and NaPi-IIa; co-expression of MAP17 with NHERF3 or NHERF4 (but not NHERF1/2) causes internalization of NaPi-IIa, MAP17, and the PDZ protein to the trans-Golgi network via a PKC-dependent mechanism. |
Bacterial and mammalian two-hybrid systems, functional studies in opossum kidney (OK) cells, PKC inhibitor/activator treatment, immunofluorescence |
American journal of physiology. Renal physiology |
Medium |
16926447
|
| 2007 |
PDZK1 is required for cAMP- and Ca2+-dependent inhibition of NHE3 activity in native colonic enterocytes; PDZK1 ablation abolishes forskolin- and ionomycin-mediated inhibition of NHE3 while hyperosmolarity-mediated inhibition remains intact. PDZK1 loss does not alter NHE3 abundance or brush-border localization in colon. |
Fluorometric NHE3 transport assay in BCECF-loaded colonic crypts, Western blot, immunohistochemistry, qPCR, PDZK1-null mice |
The Journal of physiology |
High |
17395628
|
| 2007 |
PDZK1 (CAP70) binds to inducible nitric oxide synthase (NOS2) via the four C-terminal amino acids of NOS2, enhancing NOS2 cytochrome c reductase and NO-synthase activities, increasing the population of active NOS2 dimers, and participating in apical targeting of NOS2 in polarized epithelial cells (in combination with N-terminal palmitoylation). |
Co-immunoprecipitation, enzyme activity assays, subcellular localization by immunofluorescence in polarized cells |
Molecular biology of the cell |
Medium |
17507652
|
| 2007 |
PDZK1 ablation in mouse small intestine causes severe defect in electroneutral Na+ absorption and mild reduction of CFTR-mediated anion secretion; NHE3 brush-border expression is unaffected, but NHE3 mRNA is increased, suggesting increased NHE3 turnover due to reduced membrane retention without PDZK1. |
Short circuit current measurements, 22Na+ flux assays, qPCR, Western blot, immunohistochemistry in pdzk1-/- mice |
Pflugers Archiv : European journal of physiology |
High |
17347851
|
| 2008 |
PDZK1 is expressed in endothelium and required for HDL/SR-BI-induced Src phosphorylation, endothelial NO synthase (eNOS) activation, and cell migration; PDZK1 is not required for SR-BI abundance, plasma membrane localization, HDL binding, or cholesterol efflux in endothelium. PDZK1-/- mice fail to re-endothelialize after carotid artery injury. |
Co-immunoprecipitation (Src-SR-BI interaction), siRNA knockdown, eNOS activity assay, cell migration assay, carotid artery re-endothelialization in PDZK1-/- mice (including liver-specific reconstitution controls), cell surface biotinylation |
Circulation research |
High |
18174467
|
| 2008 |
PDZK1 regulates intestinal oligopeptide transporter PEPT1 (Slc15a1) and carnitine transporter OCTN2 (Slc22a5): PDZK1 physically interacts with PEPT1, and loss of PDZK1 reduces apical membrane localization and protein levels of both transporters, delaying GI absorption of their substrates. |
Co-immunoprecipitation (PEPT1-PDZK1 from mouse small intestine), immunohistochemistry, Western blot of brush-border membranes, electron microscopy, pharmacokinetic studies in pdzk1-/- mice, functional transport assay in HEK293 cells |
Drug metabolism and disposition |
High |
18322073
|
| 2009 |
PDZK1 undergoes head-to-tail intramolecular association: the C-terminal tail of PDZK1 interacts with its first PDZ domain, inducing a compact conformation. PDZK1 also forms modest homodimers via its third PDZ domain. The tail-PDZ1 intramolecular interaction does not affect binding of PDZ domain ligands of PDZK1 itself, but negatively regulates the interaction of PDZK1's tail with the PDZ domains of EBP50/NHERF1. |
In vitro binding assays, co-immunoprecipitation, size exclusion chromatography, limited proteolysis |
Biochemistry |
Medium |
19173579
|
| 2009 |
PDZK1 (NHERF3) directly binds the NHE3 C-terminus (between amino acids 588-667), co-immunoprecipitates with NHE3 in vivo, co-localizes at the plasma membrane under basal conditions, and reconstitutes Ca2+-dependent inhibition of NHE3 activity by dissociating from NHE3 upon elevated intracellular Ca2+. NHERF3 knockdown reduces basal NHE3 activity and brush border expression in Caco-2BBe cells. |
In vitro binding assay, co-immunoprecipitation, confocal microscopy, FRET, fluorometric NHE3 transport assay, shRNA knockdown |
The Journal of biological chemistry |
High |
19535329
|
| 2009 |
Pdzk1 ablation reduces basal HCO3- secretion in mouse duodenum but not FSK-stimulated secretion, distinguishing PDZK1's role from NHERF1 (obligatory for beta2-AR stimulation) and NHERF2 (mediates LPA inhibition of CFTR). PDZK1 reduction of basal CFTR-mediated secretion indicates a role in tonic CFTR regulation. |
Duodenal HCO3- secretion measurements, laser microdissection, qPCR, Nherf/Pdzk1 knockout mouse models |
The Journal of clinical investigation |
High |
19221439
|
| 2010 |
PDZK1 binding (via C-terminal PDZ motif) promotes cell surface expression of Oatp1a1, and serine phosphorylation at S634/S635 (upstream of the PDZ motif) negatively regulates surface retention: phosphomimetic oatp1a1 remains intracellular even with PDZK1 co-expression. Extracellular ATP-induced phosphorylation of Oatp1a1 triggers rapid internalization in hepatocytes. |
Site-directed mutagenesis, transfection in HEK293T and HuH7 cells, surface biotinylation internalization assay, co-immunoprecipitation, confocal imaging, primary rat hepatocyte experiments |
American journal of physiology. Gastrointestinal and liver physiology |
High |
21183661
|
| 2010 |
PDZK1 knockdown in hepatoma cells significantly reduces susceptibility to HCV infection; this effect requires more than just the first PDZ domain of PDZK1. PDZK1 facilitates HCV entry indirectly via its interaction with SR-BI, which serves as an HCV entry factor, and this interaction requires the C-terminal PDZ-interacting residue of SR-BI. |
Stable shRNA knockdown, PDZK1 overexpression rescue, GFP-SR-BI C-terminus chimera competition, HCV infection assay in Huh-7 cells |
PLoS pathogens |
Medium |
20949066
|
| 2011 |
PDZK1 is required for apical membrane expression of NaPi-2c (but not NaPi-2a) in renal proximal tubule; FRET measurements show both NaPi-2a and NaPi-2c interact with PDZK1, but NaPi-2a shows stronger FRET with NHERF-1. In low-Pi adaptation, NaPi-2c/PDZK1 and NaPi-2a/NHERF-1 interactions increase, explaining differential regulation. |
Pdzk1-/- mice on low Pi diets, Western blot, immunofluorescence, FRET in transfected cells |
The Journal of biological chemistry |
High |
21388960
|
| 2011 |
PDZK1 physically interacts with BCRP (breast cancer resistance protein) and is required for apical membrane localization of BCRP in mouse small intestine; PDZK1 co-expression in MDCKII/BCRP cells increases basal-to-apical transcellular transport and drug resistance to SN-38. |
Pull-down assay, co-immunoprecipitation, immunohistochemistry, Western blot of brush-border membranes, transcellular transport assay, cytotoxicity assay in MDCKII cells, pdzk1-/- mice pharmacokinetics |
Drug metabolism and disposition |
High |
21816982
|
| 2012 |
PDZK1 specifically interacts with PLC-β3 (not PLC-β1) and assembles a ternary complex with PLC-β3 and somatostatin receptors (SSTRs), enabling specific activation of PLC-β3 by somatostatin. Disruption of this ternary complex inhibits SST-induced PLC activation, intracellular Ca2+ mobilization, and ERK1/2 phosphorylation. |
PDZ protein screen, co-immunoprecipitation, siRNA knockdown of PDZK1 or PLC-β3, Ca2+ mobilization assay, ERK1/2 phosphorylation assay |
The Journal of biological chemistry |
High |
22528496
|
| 2013 |
PDZK1 expression in breast cancer cells promotes estrogen-mediated cell proliferation through enhancement of c-Myc expression; PDZK1 interacts with the Src/ER-α/EGFR complex and enhances EGFR-stimulated MEK/ERK1/2 signaling. PDZK1 expression is indirectly regulated by ER-α stimulation, requiring IGF-1R function. |
siRNA knockdown, ectopic overexpression, co-immunoprecipitation, proliferation assay, immunoblotting for signaling intermediates, tissue microarrays |
Molecular medicine |
Medium |
23821363
|
| 2014 |
PDZK1 directly interacts with OATP1A2 via its C-terminal PDZ-binding domain and increases OATP1A2 surface expression by decreasing clathrin-dependent (but not caveolin-dependent) internalization, and by enhancing OATP1A2 protein stability, resulting in increased V(max) of estrone-3-sulfate transport. |
Co-immunoprecipitation, surface biotinylation, internalization assay with clathrin/caveolin inhibitors, cycloheximide chase for stability, transport functional assay in HEK293 cells |
PloS one |
High |
24728453
|
| 2017 |
PDZK1 inhibits SHP-1 phosphorylation at Tyr536 by blocking the association between SHP-1 and PLCβ3, thereby promoting STAT5 phosphorylation and retarding Akt phosphorylation in renal cell carcinoma cells. |
PDZK1 overexpression and knockdown models, co-immunoprecipitation, immunoblotting for phosphoproteins, xenograft tumor studies |
Oncogene |
Medium |
28692056
|
| 2018 |
HNF4A directly binds the rs1967017 region of the PDZK1 promoter/enhancer and transcriptionally regulates PDZK1 expression; siRNA depletion of HNF4A reduces endogenous PDZK1 in HepG2 cells. The urate-increasing T allele of rs1967017 strengthens the HNF4A binding site, enhancing PDZK1 expression. |
siRNA knockdown, luciferase reporter assay, ChIP (HNF4A binding), zebrafish transgenic reporter, eQTL analysis |
Human molecular genetics |
Medium |
30124855
|
| 2019 |
PDZK1 directly binds PTEN through its PDZ domains interacting with the PTEN C-terminus, and this interaction inhibits phosphorylation of PTEN at the S380/T382/T383 cluster, thereby enhancing PTEN's capacity to suppress PI3K/AKT signaling and gastric cancer cell proliferation. |
Co-immunoprecipitation, GST pull-down, site-directed mutagenesis, PDZK1 knockdown and overexpression, phospho-specific immunoblotting, in vitro and in vivo (xenograft) proliferation assays |
Cancer letters |
High |
30930234
|
| 2019 |
PDZK1 interacts with sodium-coupled monocarboxylate transporters SMCT1 (SLC5A8) and SMCT2 (SLC5A12) via their C-terminal PDZ motifs; PDZK1 co-expression enhances nicotinate transport activity in SMCT1-expressing HEK293 cells. PDZK1, SMCT1, and URAT1 assemble into a trimolecular complex in vitro and co-localize in renal proximal tubule in vivo. |
Yeast two-hybrid, co-immunoprecipitation, functional transport assay in HEK293 cells, immunohistochemistry |
The journal of physiological sciences |
Medium |
30604288
|
| 2022 |
HDL-mediated protection against macrophage necroptosis requires SR-B1 and PDZK1 in a PI3K/Akt pathway-dependent manner; PDZK1 knockout in bone marrow-derived cells (not liver) increases atherosclerosis and necrotic core formation, which is reversed by restoring PDZK1 in BM-derived cells. |
Bone marrow transplantation reconstitution, PDZK1-/- LDLRKO mice, macrophage necroptosis assay, PI3K inhibitor, immunohistochemistry for RIPK3/MLKL |
Arteriosclerosis, thrombosis, and vascular biology |
High |
36353992
|
| 2024 |
PDZK1 deficiency in chondrocytes impairs mitochondrial function (decreased mtDNA content, increased ROS, accumulation of damaged mitochondria) during mechanical overload by increasing ubiquitination and thereby reducing expression of Hmgcs2; PDZK1 loss exacerbates mechanical overload-induced chondrocyte senescence and cartilage degeneration. |
Pdzk1 chondrocyte knockout and AAV-PDZK1 intraarticular injection, mRNA sequencing, ubiquitination assay, mitochondrial function assays (ROS, mtDNA content, mitochondrial morphology), mechanical overload OA model |
Bone research |
Medium |
39019845
|